Arvin S. Yang
University of Siena
1 paper in the Anchorcite directory, published in 2015, cited 8,341 times in total.
Research topics
- Cancer Immunotherapy and Biomarkers · 1 paper
- Cutaneous Melanoma Detection and Management · 1 paper
- Melanoma and MAPK Pathways · 1 paper
Frequent co-authors
- James Larkin · 1 paper
- Vanna Chiarion‐Sileni · 1 paper
- Rene C. Gonzalez · 1 paper
- Jean‐Jacques Grob · 1 paper
- Charles Lance Cowey · 1 paper
- Christopher D. Lao · 1 paper
- Dirk Schadendorf · 1 paper
- Reinhard Dummer · 1 paper
Papers
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated MelanomaNew England Journal of Medicine · 2015 · 8,341 citations
BACKGROUND: Nivolumab (a programmed death 1 [PD-1] checkpoint inhibitor) and ipilimumab (a cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4] checkpoint inhibitor) have been shown to have complementary activity in metastatic melanoma. In this randomized, double-blind, phase 3 study, nivolumab alone or nivolumab…
Metadata from OpenAlex (CC0).